SGFG
PRAX icon

Silver Grove Financial Group’s Praxis Precision Medicines PRAX Stock Holding History

Silver Grove Financial Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Buy
+2
New +$633 ﹤0.01% 1993

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Silver Grove Financial Group's PRAX Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 2 shares worth $670. The stake represents ﹤0.01% of the portfolio and ranks #1993 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Silver Grove Financial Group held 2 shares of Praxis Precision Medicines worth $670 as of Q2 2026.
  • Praxis Precision Medicines was a new Silver Grove Financial Group position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #1993 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.